Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zimura in Autosomal Recessive Stargardt Disease
NCT03364153Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2018
- Primary completion
- Mar 2025
- Modality
- RNA Aptamers, DNA Aptamers
- Countries
- 8
01
Overview
A Phase 2 trial of avacincaptad pegol in Stargardt disease (STGD), sponsored by Astellas Pharma. Started Jan 2018; status: completed.
02
Drugs
avacincaptad pegol
03
Conditions
Stargardt disease (STGD)
Beyond the preview
Go deeper on NCT03364153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364153.